4.7 Article

Incorporating Multisource Knowledge To Predict Drug Synergy Based on Graph Co-regularization

Journal

JOURNAL OF CHEMICAL INFORMATION AND MODELING
Volume 60, Issue 1, Pages 37-46

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.jcim.9b00793

Keywords

-

Funding

  1. National Natural Science Foundation of China [61873089, 61862025, 61602283, 61572180]
  2. Shandong Provincial Natural Science Foundation [ZR2016FB10]
  3. Jiangxi Provincial Natural Science Foundation of China [20181BAB211016]

Ask authors/readers for more resources

Drug combinations may reduce toxicity and increase therapeutic efficacy, offering a promising strategy to conquer multiple complex diseases. However, due to large-scale combinatorial space, it remains challenging to identify effective combinations. Although many computational methods have focused on predicting drug synergy to reduce combinatorial space, they fail to effectively consider multiple sources of important knowledge. Thus, it is necessary to propose a computational method that can exploit useful information to predict drug synergy. Here, we developed a computational method to predict drug synergy based on graph co-regularization, named DSGCR. By incorporating drug-target network patterns, pharmacological patterns, and prior knowledge of drug combinations, DSGCR performs predictions of synergistic drug combinations. Compared to several existing methods, DSGCR achieves superior performance in predicting drug synergy in terms of various metrics via cross-validation. Additionally, we analyzed the importance of various sources of drug knowledge concerning three DSGCRs scenarios. Finally, the potential of DSGCR to score drug synergy was confirmed by three predicted synergistic drug combinations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available